|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.69 USD | -1.40% |
|
+4.39% | +34.56% |
Atara Biotherapeutics, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 7.89 million. Revenue was USD 8.57 million compared to USD 63.57 million a year ago.
Net loss was USD 276.13 million compared to USD 228.3 million a year ago. Basic loss per share from continuing operations was USD 2.61 compared to USD 2.24 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +34.56% | 82.36M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
ATARA BIOTHERAPEUTICS, INC. 
